Obesity Treatment Market
Obesity Treatment Market - Global Industry Assessment & Forecast
#
Pages:
140
2022
Feb - 2022
VMR-1326
Segments Covered
By
Surgery Adjusting gastric Banding, Roux-en-Y Gastric Bypass, Sleeve gastrectomy, Biliopancreatic diversion with Duodenal Switch, Endoscopic Procedures
-
By
Drugs Appetite suppressants, Combination drugs, Malabsorption, Satiety drugs
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 11.63 Billion |
 Revenue 2030:
|
USD 38.95 Billion |
 Revenue CAGR
(2023 - 2030): |
16.30% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Research Methodology: Obesity Treatment Market by Surgery by Drugs by Region - Global Market Assessment, 2021 - 2028
Secondary Research
Primary Research:
The next stage involves the primary research conducted to gather further information and revalidate the data collected from the secondary research. Moreover, primary research is also conducted to identify key players in the market and to gather their market-specific financial information. A typical primary interview fulfills data requirements pertaining to first-hand information global market size, regional and segmental trends, competitive landscape expertise development and market understandings among others.
Data Triangulation and Market Size Estimations
Top-down and bottom-up approaches are used to validate and estimate the market size of the Obesity Treatment market. After the determination of the overall market size, the market is divided into various segments and sub-segments. Moreover, these same approaches mentioned above were used to derive and estimate market numbers for mentioned segments/sub-segments in the market. The data was triangulated by employing various data models and statistical techniques to arrive at exact statics and market size for each segment/sub-segment of the market.
FAQ
Frequently Asked Question
What is the global demand for Obesity Treatment in terms of revenue?
-
The global Obesity Treatment valued at USD 11.63 Billion in 2022 and is expected to reach USD 38.95 Billion in 2030 growing at a CAGR of 16.30%.
Which are the prominent players in the market?
-
The prominent players in the market are VIVUS Inc. (US), Arena Pharmaceuticals Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Novo Nordisk A/S (Denmark), Allergan Plc (US), Medtronic (US), Ethicon (a subsidiary of Johnson & Johnson) (US), Cousin Biotech (France), EnteroMedics Inc. (US), and USGI Medical Inc. (US)..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 16.30% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Obesity Treatment include
- Rise in Healthcare Expenditure
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Obesity Treatment in 2022.
